IN Brief:
- FSSAI has questioned classifications and online descriptions of selected Nescafé ready-to-drink beverages.
- Its other notices concern Nestlé Resource Renal approval and labelling, and claims on two Horlicks nutrition products.
- Nestlé India and Hindustan Unilever have been asked to respond; the notices are not final regulatory findings.
The Food Safety and Standards Authority of India has issued notices to Nestlé India and Hindustan Unilever over product descriptions, approval requirements and nutrition claims involving several beverages and specialist foods. Publicised on 17 October 2026, the action asks the companies to explain the regulator's concerns under applicable food standards. The product groups raise separate questions, ranging from the classification of ready-to-drink coffee to substantiation of health-related messages on nutrition products. The notices begin a regulatory process; their allegations are not final findings against the manufacturers.
Nestlé India is involved in two different sets of questions. FSSAI has challenged packaging and online descriptions used for selected Nescafé ready-to-drink products, while its notice concerning Resource Renal Vanilla Flavour Powder relates to approval and labelling requirements for a specialised nutrition product. Hindustan Unilever has been asked to address claims associated with Horlicks Women's Plus Chocolate Nutrition Drink and Horlicks Mother's Plus Kesar. The breadth of the action makes the wording and regulatory category of each product important to understanding the regulator's position.
The Nescafé products identified in reporting include Intense Café Cappuccino, Choco Mocha and Chilled Latte. FSSAI has questioned differences between front-of-pack descriptions referring to flavoured milk and other declarations that present the beverages as proprietary dairy-based drinks. Online retail descriptions also formed part of the regulator's concerns. India's standards distinguish products falling within specified categories from proprietary formulations, and those classifications inform the compositional and labelling requirements against which a product is assessed. The regulator is seeking explanations for the inconsistencies it identified.
Classification decisions connect recipe development with commercial artwork. Product developers establish the composition and processing specification, regulatory specialists determine the category and required declarations, and packaging teams apply the approved description. E-commerce listings create an additional channel for the same product information. Where the website and physical pack use different categories, the manufacturer needs to reconcile them against the applicable standards. That process explains the significance of FSSAI's coffee-product concerns without implying that a particular production line has been found defective.
Resource Renal Vanilla Flavour Powder raises a separate issue under India's rules for health supplements, foods for special dietary use and foods for special medical purpose. The product is intended for the dietary management of people with chronic kidney disease undergoing conservative treatment. According to the regulator's publicised position, required prior approval had not been obtained, and a mandatory vegetarian or non-vegetarian symbol was missing from the labelling. Those questions concern the authorisation route and product information for a specialist formula. Nestlé has been asked to provide its explanation.
Hindustan Unilever faces questions about claims on Horlicks Women's Plus Chocolate Nutrition Drink referring to improved bone strength over six months, healthy muscles and an absence of added sugar. Reporting on the notices identifies the use of maltodextrin among the matters considered in connection with the sugar claim, alongside questions about nutrient declarations and recommended daily amounts. Whether a particular statement complies with food law depends on the regulatory definition, exact wording and evidence supporting it. FSSAI's notice sets out objections requiring a company response rather than publishing a final judgment on each claim.
Horlicks Mother's Plus Kesar is the subject of another challenge involving statements about healthy birth weight and nutrition during pregnancy. Language associating a formulated food with an outcome for a baby carries a different substantiation burden from ordinary descriptions of ingredients, flavour or energy content. The manufacturer must be able to establish what evidence supports the claim and whether the words are permitted for the product category. FSSAI has asked the business to explain its position under the relevant rules, keeping that question distinct from the allegations concerning Women's Plus.
The notices bring product information controls into focus across manufacturing and marketing. A nutrition table may be generated from a validated formula, but the statements printed alongside it must meet additional rules for nutrient and health claims. Altered formulations, new packaging artwork and third-party online listings can each create versions of the information presented to consumers. Internal change control therefore has to connect ingredient specifications, laboratory data, label approvals and customer-facing descriptions. This is a general compliance mechanism brought into focus by the notices, rather than a corrective programme that the named companies have announced.
Public reporting says Hindustan Unilever has contested aspects of the allegations and intends to provide scientific and regulatory support for its claims. The regulator has requested responses within the applicable periods, and the next procedural step is consideration of those submissions. Different outcomes may follow for different products because classification, prior approval, nutrition declarations and health claims are governed by different provisions. The confirmed October event is the opening of formal regulatory scrutiny across four named product groups, with decisions on any subsequent action dependent on those responses and the authority's findings.
